Business Case

M&A strategy and target screening for a corporate leader in its niche market

A mid-size pharma wanted to understand the core market in niche TAs (including addiction, anesthesia, etc.) and identify potential M&A targets to drive EU market consolidations exercise. LSC supported the company by market mapping TAs of interest, including competitive assessment and company positioning in European market, developed a strategic plan, including a 5 years vision for a growth path via M&A and identified potential targets for EU market consolidation via M&A (including both Plug&Play and Carve-Outs from larger companies).​